초록

Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement.

대표청구항 ▼

1. A therapeutic administration system comprising: one or more modules for obtaining a flow-change indicative measurement;one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;a first dispen

1. A therapeutic administration system comprising: one or more modules for obtaining a flow-change indicative measurement;one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;a first dispenser operable for dispensing at least a lytic material;a second dispenser operable for targeting an implant site; anda wireless-communication device operable for communicating a selection of the first dispenser or the second dispenser. 2. The therapeutic administration system of claim 1 in which the one or more modules for obtaining a flow-change-indicative measurement comprise: a module for programming an implantable device. 3. The therapeutic administration system of claim 1 in which the one or more modules for obtaining a flow-change-indicative measurement comprise: a turbulence-indicative auditory valve as the flow-change-indicative measurement. 4. The therapeutic administration system of claim 1 in which the one or more modules for obtaining a flow-change-indicative measurement comprise: a module for detecting one or more conditions optically. 5. The therapeutic administration system of claim 4 in which the one or more modules for obtaining a flow-change-indicative measurement comprise: a turbulence-indicative auditory value as the flow-change-indicative measurement. 6. The therapeutic administration system of claim 1 in which the one or more modules for obtaining a flow-change-indicative measurement comprise: a module for detecting one or more force-change-indicative values. 7. The therapeutic administration system of claim 6 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: a module for causing one or more dispensations in response to an apparent problem in the flow-change-indicative measurement. 8. The therapeutic administration system of claim 6, further comprising: a thrombolytic-agent-containing dispenser responsive to the decision whether to administer the one or more clot-reducing agents. 9. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: a module for deciding upon at least one of the one or more clot-reducing agents in response to obtaining an anomalous value as the flow-change-indicative measurement. 10. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: a module for signaling at least an anticoagulant of the one or more clot-reducing agents in response to an apparent flow degradation. 11. The therapeutic administration system of claim 10 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: a module for one or more dispensations in response to an apparent problem in the flow-change-indicative measurement. 12. The therapeutic administration system of claim 1 in which one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: one or more instructions responsive to a flow-force-responsive element. 13. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: one or more instructions responsive to an optical sensor. 14. The therapeutic administration system of claim 13, further comprising: a thrombolytic-agent-containing dispenser responsive to the decision whether to administer the one or more clot-reducing agents. 15. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: one or more instructions responsive to an auditory sensor. 16. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: a module for causing one or more dispensations in response to an apparent problem in the flow-change-indicative measurement. 17. The therapeutic administration system of claim 1, further comprising: a thrombolytic-agent-containing dispenser responsive to the decision whether to administer the one or more clot-reducing agents. 18. The therapeutic administration system of claim 1, further comprising: an implant-site-targeting dispenser responsive to the decision whether to administer the one or more clot-reducing agents. 19. The therapeutic administration system of claim 1 in which the one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement comprise: a module for signaling at least an anticoagulant of the one or more clot-reducing agents in response to an apparent flow degradation. 20. A therapeutic administration system comprising: one or more modules for obtaining a flow-change-indicative measurement;one or more modules for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;a first dispenser operable for dispensing at least a clot-reducing agent;a second dispenser operable for targeting an implant site; anda wireless-communication device operable for communicating a selection of the first dispenser or the second dispenser. 21. A therapeutic administration method comprising: obtaining a flow-change-indicative measurement;signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;dispensing, from a first dispenser, at least a lytic material;targeting, utilizing a second dispenser, an implant site andcommunicating, using a wireless-communication device, a selection of the first dispenser or the second dispenser.